Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 500288 | NSE Symbol : MOREPENLAB | ISIN : INE083A01026 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
03-Feb-2025	06-Feb-2025	Quarterly Results	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 inter alia to consider and approve unaudited financial results for the quarter ended December 31 2024. Please find attached results and LLR - Q3 FY 25 (As Per BSE Announcement dated on 06.02.2025)
14-Jan-2025	14-Jan-2025	Others	Please find attached outcome of Board Meeting.
06-Nov-2024	11-Nov-2024	Quarterly Results	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended on September 30 2024. Please find attached results and LLR - Q2 FY 25 (As Per BSE Announcement Dated on 11.11.2024)
27-Aug-2024	27-Aug-2024	Change in Directors	Please find enclosed letter comprising outcome of board meeting held on 27-August-2024. Please find enclosed update on disclosure submitted on August 27, 2024. (As per BSE Announcement Dated on 14/10/2024)
07-Aug-2024	12-Aug-2024	Quarterly Results	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we hereby inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 12th August 2024 inter-alia to consider and approve the following items: a. Un-audited standalone and consolidated financial results for the quarter ended 30th June 2024. b. Declaration of dividend for the financial year 2023-24. c. The record date for the declaration of dividend for the financial year 2023-24. Purpose of the meeting has been revised The company hereby recalls the items (b) above, i.e., proposal of declaration of final dividend for the financial year 2023-24 as the same was not placed before the Board of Directors while the approving annual financial statement for the financial 2023-24, in their meeting held on 21st May 2024; and (c) the record date. Kindly accept our sincere apologies for the inconvenience caused. Subject: Intimation of Board Meeting dated 7th August 2024 - Rectification Dear Sir/Ma'am, Reference is invited to our intimation letter dated 7th August 2024 wherein it was informed that a meeting of Board of Directors of the company is scheduled to be held on Monday, 12th August 2024, inter-alia, to consider and approve (a) the unaudited standalone and consolidated financial results of the company for the quarter ended 30th June 2024, (b) declaration of final dividend for the financial year 2023-24 and; (c) record date. The company hereby recalls the items (b) above, i.e., proposal of declaration of final dividend for the financial year 2023-24 as the same was not placed before the Board of Directors while the approving annual financial statement for the financial 2023-24, in their meeting held on 21st May 2024; and (c) the record date. Kindly accept our sincere apologies for the inconvenience caused. (As Per BSE Announcement dated on 08.08.2024) Please find enclsoed results for the Q1 FY 25. (As Per BSE Announcement Dated on 12.08.2024)
14-May-2024	21-May-2024	Accounts	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 inter alia to consider and approve standalone and consolidated audited financial results for the quarter and financial year ended 31st March 2024. Please find enclosed audited Standalone and consolidated financial results - Q4-FY24 (As Per BSE Announcement Dated on 21/05/2024)
19-Feb-2024	22-Feb-2024	Raising funds through Debt Instr.	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/02/2024 inter alia to consider and approve raising of funds and approval of notice of extra-ordinary general meeting or postal ballot as the case may be for obtaining approval of members. PFA (As per BSE Announcement Dated on 22/02/2024)
24-Jan-2024	31-Jan-2024	Quarterly Results	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve standalone and consolidated unaudited financial results for the quarter and nine months ended on 31/12/2023. Please find enclosed Q-3 results along with LLR. Unaudited Financial Results for Q3 FY 24 and intimation of Senior Management Personnel. (As Per BSE Announcement Dated on 31/01/2024) Please find attached details. (As Per BSE Announcement dated on 01.02.2024)
26-Oct-2023	02-Nov-2023	Quarterly Results	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve the standalone and consolidated un-audited financial results of the company for the quarter and half year ended September 30 2023. Please find attached financial results for the quarter and half year ended on September 30, 2023 along-with limited review report thereon. (As Per BSE Announcement Dated on 02.11.2023)
14-Aug-2023	14-Aug-2023	Scheme of Arrangement	Disclosure under Regulation 30 of SEBI(LODR) Regulations, 2015
29-Jul-2023	05-Aug-2023	Quarterly Results	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 inter alia to consider and approve the unaudited financial results for the quarter ended 30th June 2023 MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 ,inter alia, to consider and approve the unaudited financial results for the quarter ended 30th June 2023 Unaudited financial results for the quarter ended 30th June 2023 Re-appointment of Mr. Sushil Suri as Chairman & Managing Director of the company with effect from 20 October 2023, for three years. (As Per BSE Announcement Dated on 05.08.2023)
09-May-2023	16-May-2023	Accounts	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 inter alia to consider and approve the standalone and consolidated audited financial results of the company for the quarter and financial year ended 31st March 2023. This is to inform you that the Board of Directors of the company, in their meeting held on Tuesday, 16th May 2023 (commenced at 11.30 A.M. and concluded at 04:15 P.M.), have, inter-alia, considered and approved audited standalone and consolidated financial results of the company for the quarter and financial year ended 31st March 2023, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. A copy of the 'Results' along with the report of the auditors of the company, with unmodified opinion, thereon and a declaration to that effect, are enclosed herewith. (As Per BSE Announcement Dated on 16.05.2023)
04-Feb-2023	13-Feb-2023	Quarterly Results	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve the standalone and consolidated un-audited financial results of the company for the quarter and nine months ended 31st December 2022 This is to inform you that the Board of Directors of the company, in their meeting held on Monday, 13th February 2023 (commenced at 11:00 A.M. and concluded at 01:40 P.M.), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the company for the quarter and nine months ended 31st December 2022, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the company for the quarter and nine months ended 31st December 2022, are enclosed herewith. (As Per BSE Announcement Dated on 13/02/2023)
02-Feb-2023	02-Feb-2023	Change in Company Name	Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that the Board of Directors at their meeting held today i.e., Thursday, February 2, 2023 (commenced at 12:30 P.M. and concluded at 02:00 P.M.), inter-alia, considered and approved to change the name of the company from 'MOREPEN LABORATORIES LIMITED' to 'MOREPEN LIMITED' or any other name as may be available and approved by the Registrar of Companies, accordingly amendment in Memorandum of Association of the company with respect to said change of name, subject to the necessary approvals of Stock Exchanges, members and others, as may be required.
03-Nov-2022	10-Nov-2022	Quarterly Results	MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 inter alia to consider and approve the standalone and consolidated un-audited financial results of the company for the quarter and half year ended 30th September 2022. This is to inform you that the Board of Directors of the company, in their meeting held on Thursday, 10th November 2022 (commenced at 11:00 A.M. and concluded at 01:25 P.M.), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the company for the quarter and half year ended 30th September 2022, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As per BSE Announcement Dated on 10/11/2022)

1 2 3

LOGIN HERE

Morepen Laboratories Ltd

Board Meeting